<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recently published guidelines from the National Institute for Health and Clinical Excellence recommend using a two-stage approach to identify those at high risk of developing Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>: screening using a validated self-assessment questionnaire or computer-based risk assessment tool, followed (in those with a high risk score) by a blood test for either HbA(1c) or fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> [1] </plain></SENT>
<SENT sid="1" pm="."><plain>The presence of a fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> level of 5.5-6.9 mmol/l or HbA(1c) 42-47 mmol/mol categorizes a person as high risk for progression to Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We assessed the practical impact of this screening strategy in a cohort of 2253 participants aged over 40 years, and not known to have <z:mp ids='MP_0002055'>diabetes</z:mp>, recruited from the Exeter 10000 study. © 2012 The Authors </plain></SENT>
<SENT sid="3" pm="."><plain>Diabetic Medicine © 2012 <z:mp ids='MP_0002055'>Diabetes</z:mp> UK </plain></SENT>
</text></document>